Valuation: Össur hf.

Market Cap 1.72B 216B 1.51B 1.39B 1.28B 2.42B 166B 2.46B 16.58B 6.51B 81B 6.47B 6.33B 279B P/E 2026 *
18.6x
P/E 2027 * 15.9x
Enterprise Value 2.12B 266B 1.85B 1.71B 1.57B 2.98B 204B 3.03B 20.42B 8.01B 99.76B 7.97B 7.79B 344B EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.89x
Free-Float
36.17%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 48 31/03/2022
Director of Finance/CFO 60 31/08/2022
Chief Tech/Sci/R&D Officer - 23/02/2025
Director TitleAgeSince
Director/Board Member 58 31/12/2008
Chairman 68 31/12/2005
Director/Board Member 61 31/01/2008
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.33% - - 1.73B
+0.34%-2.21%+0.19%-28.68% 20.45B
+1.37%-0.10%-9.87%-13.27% 15.03B
+0.65%-2.40%-58.83%-46.17% 5.63B
+8.03%+3.86% - - 3.65B
+2.39%-1.38%+36.79%+9.64% 1.6B
-1.21%+9.23%-38.55%-60.33% 1.22B
+6.35%+10.32%+79.91%+142.90% 864M
+0.30%-1.93%+11.04%+166.26% 454M
+5.77%-5.91% - - 247M
Average +2.40%-1.29%+2.95%+24.34% 5.46B
Weighted average by Cap. +1.37%-2.16%-8.62%-20.01%

Financials

2026 *2027 *
Net sales 1.02B 127B 890M 821M 755M 1.43B 97.97B 1.45B 9.8B 3.85B 47.89B 3.82B 3.74B 165B 1.1B 138B 962M 887M 815M 1.55B 106B 1.57B 10.59B 4.16B 51.73B 4.13B 4.04B 178B
Net income 93.16M 11.66B 81.45M 75.14M 69.07M 131M 8.96B 133M 897M 352M 4.38B 350M 342M 15.1B 108M 13.53B 94.53M 87.2M 80.16M 152M 10.4B 154M 1.04B 408M 5.08B 406M 397M 17.53B
Net Debt 399M 49.92B 349M 322M 296M 560M 38.37B 570M 3.84B 1.51B 18.75B 1.5B 1.46B 64.64B 358M 44.76B 313M 288M 265M 502M 34.4B 511M 3.44B 1.35B 16.82B 1.34B 1.31B 57.96B
Logo Össur hf.
Embla Medical hf, formerly Ossur hf, is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
26.40DKK
Average target price
32.90DKK
Spread / Average Target
+24.62%

Quarterly revenue - Rate of surprise